Article Details

CDSCO approves AstraZeneca's anti-complement medicine Eculizumab - Express Pharma

Retrieved on: 2025-01-17 16:04:40

Tags for this article:

Click the tags to see associated articles and topics

CDSCO approves AstraZeneca's anti-complement medicine Eculizumab - Express Pharma. View article details on hiswai:

Excerpt

AstraZeneca completed the acquisition of Alexion in 2021 and continues to expand its portfolio with the aim of bringing innovative therapies for ...

Article found on: www.expresspharma.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up